{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:31:21Z","timestamp":1792002681116,"version":"4.4.0"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Urinary tract infections are prone to overdiagnosis, and reflex urine culture protocols offer a valuable opportunity for diagnostic stewardship in this arena. However, there is no recommended standard testing approach. Patients with cancer are often excluded from reflex urine culture protocols, especially if they are severely immunosuppressed or neutropenic. The aim of this study was to evaluate the performance characteristics of urine screening studies, including dipstick urinalysis for nitrite and leukocyte esterase and urine microscopy for white blood cell count, to detect significant pathogen growth.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A retrospective study of 58 098 urine cultures with a paired dipstick urinalysis with or without urine microscopy was performed at Memorial Sloan Kettering Cancer Center in New York City, evaluating data from 1 January 2018 to 31 December 2020. A dipstick urinalysis was considered negative only if leukocyte esterase and nitrite were undetected.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A negative dipstick urinalysis had a negative predictive value of 98% for clinically significant bacteriuria in voided urine and 95% for catheterized urine. Notably, a negative urine dipstick test screen maintained a high negative predictive value among patients with neutropenia and in those with antibiotic exposure before testing. Finally, the presence of pyuria \u226510 white blood cells per high-power field on urine microscopy offered negligible incremental diagnostic benefit in samples with a negative dipstick urinalysis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Reflex urine culture protocols contingent upon a screening dipstick urinalysis are a safe and effective platform for diagnostic stewardship in patients with cancer including those with neutropenia.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/cid\/ciaf018","type":"journal-article","created":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T10:29:06Z","timestamp":1736936946000},"page":"969-974","source":"Crossref","is-referenced-by-count":6,"title":["Improving Urinary Tract Infection Diagnostics in Oncology: Reliability of Reflex Urine Culture in Immunosuppressed Neutropenic and Non-neutropenic Cancer Patients"],"prefix":"10.1093","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0710-565X","authenticated-orcid":false,"given":"Justin C","family":"Laracy","sequence":"first","affiliation":[{"name":"Infection Control, Memorial Sloan Kettering Cancer Center , New York, New York ,","place":["USA"]},{"name":"Infectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center , New York, New York ,","place":["USA"]},{"name":"Department of Medicine, Weill Cornell Medical College , New York, New York ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5435-5558","authenticated-orcid":false,"given":"June L","family":"Chan","sequence":"additional","affiliation":[{"name":"Clinical Microbiology Service, Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center , New York, New York ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rich","family":"Kodama","sequence":"additional","affiliation":[{"name":"Infection Control, Memorial Sloan Kettering Cancer Center , New York, New York ,","place":["USA"]},{"name":"Infectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center , New York, New York ,","place":["USA"]},{"name":"Department of Medicine, Weill Cornell Medical College , New York, New York ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2174-218X","authenticated-orcid":false,"given":"Judy","family":"Yan","sequence":"additional","affiliation":[{"name":"Infection Control, Memorial Sloan Kettering Cancer Center , New York, New York ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9287-2407","authenticated-orcid":false,"given":"Kevin M","family":"Raible","sequence":"additional","affiliation":[{"name":"Clinical Microbiology Service, Department of Pathology and Laboratory Medicine , Portland, Oregon ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kent","family":"Sepkowitz","sequence":"additional","affiliation":[{"name":"Infectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center , New York, New York ,","place":["USA"]},{"name":"Department of Medicine, Weill Cornell Medical College , New York, New York ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"McVoy","sequence":"additional","affiliation":[{"name":"Clinical Hematology Service, Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center , New York, New York ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N Esther","family":"Babady","sequence":"additional","affiliation":[{"name":"Infectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center , New York, New York ,","place":["USA"]},{"name":"Clinical Microbiology Service, Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center , New York, New York ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mini","family":"Kamboj","sequence":"additional","affiliation":[{"name":"Infection Control, Memorial Sloan Kettering Cancer Center , New York, New York ,","place":["USA"]},{"name":"Infectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center , New York, New York ,","place":["USA"]},{"name":"Department of Medicine, Weill Cornell Medical College , New York, New York ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,1,15]]},"reference":[{"key":"2025060412025556600_ciaf018-B1","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1056\/NEJMoa1801550","article-title":"Changes in prevalence of health care-associated infections in U.S. hospitals","volume":"379","author":"Magill","year":"2018","journal-title":"N Engl J Med"},{"key":"2025060412025556600_ciaf018-B2","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/cid\/ciz764","article-title":"Outpatient urinary tract infections in an era of virtual healthcare: trends from 2008 to 2017","volume":"71","author":"Bruxvoort","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2025060412025556600_ciaf018-B3","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/cid\/ciab987","article-title":"Optimal urine culture diagnostic stewardship practice\u2014results from an expert modified-Delphi procedure","volume":"75","author":"Claeys","year":"2022","journal-title":"Clin Infect Dis"},{"key":"2025060412025556600_ciaf018-B4","doi-asserted-by":"publisher","DOI":"10.1093\/CID\/CIAE104","article-title":"Guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2024 update by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)","author":"Michael Miller","year":"2024","journal-title":"Clin Infect Dis"},{"key":"2025060412025556600_ciaf018-B5","doi-asserted-by":"crossref","first-page":"v111","DOI":"10.1093\/annonc\/mdw325","article-title":"Management of febrile neutropaenia: ESMO clinical practice guidelines","volume":"27","author":"Klastersky","year":"2016","journal-title":"Ann Oncol"},{"key":"2025060412025556600_ciaf018-B6","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/cid\/cir073","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America","volume":"52","author":"Freifeld","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2025060412025556600_ciaf018-B7","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0002-9343(78)90187-0","article-title":"Granulocytopenia in hospitalized patients: I. Prognostic factors and etiology of fever","volume":"64","author":"Gurwith","year":"1978","journal-title":"Am J Med"},{"key":"2025060412025556600_ciaf018-B8","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1007\/BF01975040","article-title":"Value of surveillance cultures in the management of neutropenic patients","volume":"7","author":"Daw","year":"1988","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2025060412025556600_ciaf018-B9","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/CJI.0000000000000346","article-title":"Effects of antibiotic use on outcomes in cancer patients treated using immune checkpoint inhibitors: a systematic review and meta-analysis","volume":"44","author":"Yu","year":"2021","journal-title":"J Immunother"},{"key":"2025060412025556600_ciaf018-B10","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.bbmt.2017.02.006","article-title":"Microbiota disruption induced by early use of broad-spectrum antibiotics is an independent risk factor of outcome after allogeneic stem cell transplantation","volume":"23","author":"Weber","year":"2017","journal-title":"Biol Blood Marrow Transpl"},{"key":"2025060412025556600_ciaf018-B11","author":"European Medicines Agency"},{"key":"2025060412025556600_ciaf018-B12","author":"FDA"},{"key":"2025060412025556600_ciaf018-B13","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1017\/ice.2020.5","article-title":"Sustained decrease in urine culture utilization after implementing a reflex urine culture intervention: a multicenter quasi-experimental study","volume":"41","author":"Howard-Anderson","year":"2020","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2025060412025556600_ciaf018-B14","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1017\/ice.2022.315","article-title":"Optimizing reflex urine cultures: using a population-specific approach to diagnostic stewardship","volume":"44","author":"Advani","year":"2023","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"3):","key":"2025060412025556600_ciaf018-B15","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1093\/cid\/ciae230","article-title":"Performance of urinalysis parameters in predicting urinary tract infection: does one size fit all?","volume":"79","author":"Advani","year":"2024","journal-title":"Clin Infect Dis"},{"key":"2025060412025556600_ciaf018-B16","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1001\/jamainternmed.2023.2749","article-title":"A statewide quality initiative to reduce unnecessary antibiotic treatment of asymptomatic bacteriuria","volume":"183","author":"Vaughn","year":"2023","journal-title":"JAMA Intern Med"},{"key":"2025060412025556600_ciaf018-B17","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/ofid\/ofac492.114","article-title":"1592. SHEA featured oral abstract: reducing unnecessary antibiotic treatment for asymptomatic bacteriuria: a statewide collaborative quality initiative","volume":"9","author":"Vaughn","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"2025060412025556600_ciaf018-B18","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nrc.2018.10","article-title":"Gut microbiota injury in allogeneic haematopoietic stem cell transplantation","volume":"18","author":"Shono","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"2025060412025556600_ciaf018-B19","doi-asserted-by":"crossref","first-page":"339ra71","DOI":"10.1126\/scitranslmed.aaf2311","article-title":"Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice","volume":"8","author":"Shono","year":"2016","journal-title":"Sci Transl Med"},{"key":"2025060412025556600_ciaf018-B20","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1056\/NEJMoa1900623","article-title":"Microbiota as predictor of mortality in allogeneic hematopoietic-cell transplantation","volume":"382","author":"Peled","year":"2020","journal-title":"New Engl J Med"},{"key":"2025060412025556600_ciaf018-B21","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/s41591-024-02803-3","article-title":"Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma","volume":"30","author":"Bj\u00f6rk","year":"2024","journal-title":"Nat Med"},{"key":"2025060412025556600_ciaf018-B22","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1126\/science.abb5920","article-title":"Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients","volume":"371","author":"Baruch","year":"2021","journal-title":"Science"},{"key":"2025060412025556600_ciaf018-B23","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1038\/s41591-023-02453-x","article-title":"Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial","volume":"29","author":"Routy","year":"2023","journal-title":"Nat Med"},{"key":"2025060412025556600_ciaf018-B24","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1001\/jamainternmed.2019.2871","article-title":"Risk factors and outcomes associated with treatment of asymptomatic bacteriuria in hospitalized patients","volume":"179","author":"Petty","year":"2019","journal-title":"JAMA Intern Med"},{"key":"2025060412025556600_ciaf018-B25","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nrurol.2011.192","article-title":"Asymptomatic bacteriuria: when the treatment is worse than the disease","volume":"9","author":"Trautner","year":"2011","journal-title":"Nature Reviews Urology"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciaf018\/61439899\/ciaf018.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/80\/5\/969\/61439899\/ciaf018.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/80\/5\/969\/61439899\/ciaf018.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T16:03:23Z","timestamp":1749053003000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/80\/5\/969\/7954260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,15]]},"references-count":25,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,1,15]]},"published-print":{"date-parts":[[2025,6,4]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciaf018","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,5,15]]},"published":{"date-parts":[[2025,1,15]]}}}